BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16105057)

  • 1. Use of a probiotic to decrease enteric hyperoxaluria.
    Lieske JC; Goldfarb DS; De Simone C; Regnier C
    Kidney Int; 2005 Sep; 68(3):1244-9. PubMed ID: 16105057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria.
    Goldfarb DS; Modersitzki F; Asplin JR
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):745-9. PubMed ID: 17699491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
    Campieri C; Campieri M; Bertuzzi V; Swennen E; Matteuzzi D; Stefoni S; Pirovano F; Centi C; Ulisse S; Famularo G; De Simone C
    Kidney Int; 2001 Sep; 60(3):1097-105. PubMed ID: 11532105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation.
    Lieske JC; Tremaine WJ; De Simone C; O'Connor HM; Li X; Bergstralh EJ; Goldfarb DS
    Kidney Int; 2010 Dec; 78(11):1178-85. PubMed ID: 20736987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery.
    Kumar R; Lieske JC; Collazo-Clavell ML; Sarr MG; Olson ER; Vrtiska TJ; Bergstralh EJ; Li X
    Surgery; 2011 May; 149(5):654-61. PubMed ID: 21295813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis.
    Duffey BG; Pedro RN; Makhlouf A; Kriedberg C; Stessman M; Hinck B; Ikramuddin S; Kellogg T; Slusarek B; Monga M
    J Am Coll Surg; 2008 Jun; 206(6):1145-53. PubMed ID: 18501812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria.
    Siener R; Bade DJ; Hesse A; Hoppe B
    J Transl Med; 2013 Dec; 11():306. PubMed ID: 24330782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
    Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
    Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of patients with enteric hyperoxaluria.
    Asplin JR
    Urolithiasis; 2016 Feb; 44(1):33-43. PubMed ID: 26645872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate.
    Canales BK; Ellen J; Khan SR; Hatch M
    J Urol; 2013 Sep; 190(3):1102-9. PubMed ID: 23499748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluria.
    D'Costa MR; Kausz AT; Carroll KJ; Ingimarsson JP; Enders FT; Mara KC; Mehta RA; Lieske JC
    Nephrol Dial Transplant; 2021 Dec; 36(12):2208-2215. PubMed ID: 33367720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass.
    Agrawal V; Liu XJ; Campfield T; Romanelli J; Enrique Silva J; Braden GL
    Surg Obes Relat Dis; 2014; 10(1):88-94. PubMed ID: 23953730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of nephrolithiasis, hyperoxaluria, and calcium oxalate supersaturation increased after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis.
    Upala S; Jaruvongvanich V; Sanguankeo A
    Surg Obes Relat Dis; 2016; 12(8):1513-1521. PubMed ID: 27396545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery.
    Asplin JR; Coe FL
    J Urol; 2007 Feb; 177(2):565-9. PubMed ID: 17222634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperoxaluria and renal calculi].
    Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
    Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxalate metabolism after intestinal bypass operations.
    Nordenvall B; Backman L; Larsson L
    Scand J Gastroenterol; 1981 Apr; 16(3):395-9. PubMed ID: 16435482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study.
    Duffey BG; Alanee S; Pedro RN; Hinck B; Kriedberg C; Ikramuddin S; Kellogg T; Stessman M; Moeding A; Monga M
    J Am Coll Surg; 2010 Jul; 211(1):8-15. PubMed ID: 20610243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Calcium and Vitamin B6 Supplementation on Oxalate Excretion in a Rodent Gastric Bypass Model of Enteric Hyperoxaluria.
    Espino-Grosso P; Monsour C; Canales BK
    Urology; 2019 Feb; 124():310.e9-310.e14. PubMed ID: 30412704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass.
    Moreland AM; Santa Ana CA; Asplin JR; Kuhn JA; Holmes RP; Cole JA; Odstrcil EA; Van Dinter TG; Martinez JG; Fordtran JS
    Gastroenterology; 2017 Apr; 152(5):1055-1067.e3. PubMed ID: 28089681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.